Shanghai Pharmaceuticals Holding (02607): Prednisolone tablets pass generic drug consistency evaluation.

18:18 24/04/2026

Shanghai Pharmaceuticals (02607) announced that recently, Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., a subsidiary of Shanghai Pharmaceuticals Group Co., Ltd. (hereinafter referred to as the "Company"), received the "Drug Supplementary Application Approval Notice" (Notice No.: 2026B02317) issued by the National Medical Products Administration (hereinafter referred to as the "NMPA") regarding prednisolone tablets (hereinafter referred to as "the drug"), indicating that the drug has passed the consistency evaluation of generic drugs.

Shanghai Pharmaceuticals Holding (02607) announced that recently, its subsidiary Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd. (referred to as "Xinyi Jinjin") received the "Drug Supplementary Application Approval Notice" (Notice No .: 2026B02317) issued by the National Medical Products Administration (referred to as the "NMPA") regarding the prednisolone tablet (referred to as "the drug"). The drug has passed the generic consistency evaluation.

XINTE ENERGY (01799) achieved a first quarter net profit attributable to shareholders of RMB 228 million.

BEIJING ENT (00392): Beijing Yanjing Brewery's net profit attributable to shareholders in the first quarter was 2.65 billion yuan, a year-on-year increase of 60.19%.

DL Holdings GP (01709) spent 1.169 million Hong Kong dollars to repurchase 1.125 million shares on April 24th.

XINTE ENERGY (01799) achieved a first quarter net profit attributable to shareholders of RMB 228 million.

BEIJING ENT (00392): Beijing Yanjing Brewery's net profit attributable to shareholders in the first quarter was 2.65 billion yuan, a year-on-year increase of 60.19%.

DL Holdings GP (01709) spent 1.169 million Hong Kong dollars to repurchase 1.125 million shares on April 24th.